APOB and Obesity: Consistent with these findings, we found that compared to nT2DM patients without MetS, patients with MetS had higher levels of parameters of adiposity (BMI and BF%), TC, TG, and apoB, and lower levels of HDL-C and apoA, suggesting that obesity and dyslipidemia play key roles in development of MetS.